Arbutus Announces Resignation of Board Member
WARMINSTER, Pa., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage
Globe Newswire27-01-2023, 19:32
GCC Enters Into a Settlement Agreement With Compañía de 11-03-2023, 07:23